1. Home
  2. FBIOP vs AGNCM Comparison

FBIOP vs AGNCM Comparison

Compare FBIOP & AGNCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIOP
  • AGNCM
  • Stock Information
  • Founded
  • FBIOP N/A
  • AGNCM N/A
  • Country
  • FBIOP United States
  • AGNCM United States
  • Employees
  • FBIOP 101
  • AGNCM 53
  • Industry
  • FBIOP Biotechnology: Pharmaceutical Preparations
  • AGNCM Real Estate Investment Trusts
  • Sector
  • FBIOP Health Care
  • AGNCM Real Estate
  • Exchange
  • FBIOP Nasdaq
  • AGNCM Nasdaq
  • Market Cap
  • FBIOP N/A
  • AGNCM N/A
  • IPO Year
  • FBIOP N/A
  • AGNCM N/A
  • Fundamental
  • Price
  • FBIOP $6.61
  • AGNCM $24.45
  • Analyst Decision
  • FBIOP
  • AGNCM
  • Analyst Count
  • FBIOP 0
  • AGNCM 0
  • Target Price
  • FBIOP N/A
  • AGNCM N/A
  • AVG Volume (30 Days)
  • FBIOP N/A
  • AGNCM N/A
  • Earning Date
  • FBIOP N/A
  • AGNCM N/A
  • Dividend Yield
  • FBIOP N/A
  • AGNCM N/A
  • EPS Growth
  • FBIOP N/A
  • AGNCM N/A
  • EPS
  • FBIOP N/A
  • AGNCM N/A
  • Revenue
  • FBIOP N/A
  • AGNCM N/A
  • Revenue This Year
  • FBIOP N/A
  • AGNCM N/A
  • Revenue Next Year
  • FBIOP N/A
  • AGNCM N/A
  • P/E Ratio
  • FBIOP N/A
  • AGNCM N/A
  • Revenue Growth
  • FBIOP N/A
  • AGNCM N/A
  • 52 Week Low
  • FBIOP N/A
  • AGNCM N/A
  • 52 Week High
  • FBIOP N/A
  • AGNCM N/A
  • Technical
  • Relative Strength Index (RSI)
  • FBIOP 58.26
  • AGNCM 46.79
  • Support Level
  • FBIOP $6.15
  • AGNCM $24.52
  • Resistance Level
  • FBIOP $6.50
  • AGNCM $24.97
  • Average True Range (ATR)
  • FBIOP 0.31
  • AGNCM 0.22
  • MACD
  • FBIOP -0.02
  • AGNCM 0.02
  • Stochastic Oscillator
  • FBIOP 75.37
  • AGNCM 24.64

About FBIOP Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

About AGNCM AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.

Share on Social Networks: